New research reveals that individuals who stop using popular weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who end conventional diet and exercise programs.
Research printed in a major health publication shows that while overweight individuals can lose substantial amounts of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using these treatments should be cognizant of the risk of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb.
That rate of recovery implies a return to original mass within about a year and a half.
Weighing Approaches
The analysis, which examined 37 of trials involving thousands of patients, contrasted the effects of these new drugs with other pills.
The team emphasize that individuals who shed pounds through lifestyle changes alone generally see a less rapid weight regain—around 0.1 kg a month—once they finish.
Understanding the Fast Rebound
Nutrition scientists suggest the mechanism of the drugs explains the accelerated rebound.
The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making excessive eating much more probable."
An Ongoing Disease?
Health authorities suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts say that, due to the likelihood of relapse, the treatment should be considered life-long.
This view is reinforced by pharmaceutical companies, who note that the results "emphasize the long-term character of excess weight," akin to managing conditions like hypertension.
User Accounts
Users who have stopped the jabs describe a sudden resurgence of hunger.
"I experienced a switch that goes on and you're instantly ravenous," described a patient.
The struggle is exacerbated if individuals have not established permanent lifestyle or habit modifications during treatment.
Significant Use
Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with desire remaining high.
- Adoption is greater among females than men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a magic fix and lasting health benefits relies on integrated lifestyle changes.
